Trazumab 440 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Trazumab 440 mg Injection

Trazumab 440 mg Injection

Trazumab 440 mg Injection contains trastuzumab and is a targeted anticancer medicine used for certain HER2-positive cancers. It works by binding to the HER2 protein and helping slow or stop the growth of cancer cells. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Trastuzumab is a monoclonal antibody that specifically targets HER2, a protein found in increased amounts on some cancer cells. Trazumab 440 mg Injection is used in treatment regimens for HER2-positive breast cancer and certain HER2-positive stomach cancers. The product is supplied as a 440 mg presentation and requires appropriate preparation and controlled intravenous administration. Patients may require monitoring for infusion reactions, heart function, blood counts, and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Powder for Solution for Infusion
Pack Size 1 vial
Route of Administration Intravenous infusion
Manufacturer Emcure Pharmaceuticals Ltd

Product Also Known As

Trazumab 440 mg, Trazumab 440 mg Injection, Trazumab 440 mg Infusion, Trastuzumab 440 mg Injection, Trastuzumab 440 mg Infusion, Trastuzumab Injection, HER2 Targeted Therapy Injection